Isolates from spent turmeric for the management of rheumatoid arthritis
US11298395B2 · kind B2 · utility
0Cited by
1References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2018 |
| Grant date | Apr 12, 2022 |
| Priority date | — |
| Expiry date | Jul 26, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2236/53
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a process for the isolation of bioactive components from spent turmeric (Curcuma longa) and compositions comprising said bioactive components. Further, the present invention also elucidates the potent anti-inflammatory activity of said bioactive compositions and therapeutic applications thereof in rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.